As opioid overprescribing is a key contributor to the current opioid crisis, implementing appropriate prescribing strategies in medical education may prepare future physicians to appropriately and ethically prescribe opioids.
The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.
In cases in which an error is made in the care of an unrepresented patient, the absence of a surrogate does not preclude the clinician’s ethical responsibilities to document, disclose, and, insofar as possible, rectify the mistake.
State medical boards should consider investigating licensees suspected of violating professional standards when providing unproven stem cell interventions, especially those advertising treatment outside their scope of training.
Healthcare providers have a high-profile and continuing dilemma: specifically whether one’s sense of duty of care to genetic relatives of a patient helps or hinders decision making in cases where a patient’s genetic information may be pertinent to the health of the patient’s family members.
Editorialists comment on a case of withdrawal of venoarterial extracorporeal membrane oxygenation in an unrepresented patient and discuss Extracorporeal Life Support Organization guidelines to make decisions, highlighting how important proportionality in a benefits-to-burdens analysis is.